← Back to IMMX

Immix Biopharma, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 07/08/2026Mar 2026Filed 07/08/2026Sep 2025Filed 07/11/2025Jun 2025Filed 07/08/2026Mar 2025Filed 07/08/2026Sep 2024Filed 07/11/2025Jun 2024Filed 08/08/2025Mar 2024Filed 08/05/2025
−$12−$10−$7.6−$6.6−$4.5−$7.1−$4.4−$5.3
−$0.18−$0.18−$0.24−$0.22−$0.15−$0.24−$0.15−$0.22
6455323030292923

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.